BriaCell Presents Positive Efficacy Data with Lead Cancer Drug Candidate in Phase IIa Monotherapy and Excellent Initial Safety Data in Combination with KEYTRUDA® at a Major Breast Cancer Conference

World News: . []

BERKELEY Calif and VANCOUVER British Columbia Dec 06 2018 GLOBE NEWSWIRE -- BriaCell Therapeutics Corp or the TSX-VBCT OTCQBBCTXF an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy te chnolog...

More news and information about BriaCell Therapeutics Corp

Published By:

Globe Newswire: 13:30 GMT Thursday 6th December 2018

Published: .

Search for other references to "briacell" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us